Opaleye Management Liquidates $4.77M in Eton Pharmaceuticals Shares Amid Strong Stock Performance
Opaleye Management Inc., a significant ten percent owner of Eton Pharmaceuticals, Inc. (NASDAQ:ETON), has executed a series of stock sales totaling approximately $4.77 million. These transactions, spanning from early July 2026, coincide with Eton's stock price approaching its 52-week high of $38.62. The sales reduce the investment firm's holdings, …